Aerie Pharmaceuticals - Company & Market Research Reports

Aerie Pharmaceuticals is a company that focuses on the development and commercialization of therapies for the treatment of glaucoma and other eye diseases. The National Eye Institute expects the number of people in the United States suffering from glaucoma to reach 4.3 million by 2030. Aerie was founded in 2005 and went in public in 2013, raising $67 million in its IPO. Its product candidates include Rhopressa and Roclatan. The company is headquartered in Irvine, California.

Ophthalmology Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Ophthalmology Drug Development Pipeline Review, 2016

  • Report
  • 633 Pages
From
Diabetic Macular Edema - Pipeline Review, H2 2018 - Product Thumbnail Image

Diabetic Macular Edema - Pipeline Review, H2 2018

  • Drug Pipelines
  • 231 Pages
From
Ocular Hypertension: Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Ocular Hypertension: Drug Development Pipeline Study, H1 2018

  • Report
  • 61 Pages
From
Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030 - Product Thumbnail Image

Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030

  • Report
  • 292 Pages
From
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2018 - Product Thumbnail Image

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 52 Pages
From
Diabetic Retinopathy - Pipeline Review, H1 2018 - Product Thumbnail Image

Diabetic Retinopathy - Pipeline Review, H1 2018

  • Drug Pipelines
  • 219 Pages
From
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2018 - Product Thumbnail Image

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 52 Pages
From
Global Glaucoma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025 - Product Thumbnail Image

Global Glaucoma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • Report
From
Ophthalmic Therapeutics/Drug Market Analysis By Class (Anti-allergy, Anti-VEGF Agents, Anti-inflammatory, Anti-glaucoma), By Disease (Dry Eye, Allergies, Glaucoma, Infection, Retinal Disorders, Uveitis), And Segment Forecasts, 2014 - 2025 - Product Thumbnail Image

Ophthalmic Therapeutics/Drug Market Analysis By Class (Anti-allergy, Anti-VEGF Agents, Anti-inflammatory, Anti-glaucoma), By Disease (Dry Eye, Allergies, Glaucoma, Infection, Retinal Disorders, Uveitis), And Segment Forecasts, 2014 - 2025

  • Report
  • 58 Pages
From
Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026 - Product Thumbnail Image

Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026

  • Report
  • 228 Pages
From
Global Glaucoma treatment Market Research and Forecast 2018-2023 - Product Thumbnail Image

Global Glaucoma treatment Market Research and Forecast 2018-2023

  • Report
From
Ophthalmic Therapeutic Drugs: Technologies and Global Markets - Product Thumbnail Image

Ophthalmic Therapeutic Drugs: Technologies and Global Markets

  • Report
  • 111 Pages
From
Glaucoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Glaucoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 299 Pages
From
Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market - Product Thumbnail Image

Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market

  • Report
  • 150 Pages
From
Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview  - Product Thumbnail Image

Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview

  • Report
  • 208 Pages
From
Wet AMD- Pipeline Insight, 2018 - Product Thumbnail Image

Wet AMD- Pipeline Insight, 2018

  • Drug Pipelines
  • 106 Pages
From
Retinal Degeneration - Pipeline Insight, 2018 - Product Thumbnail Image

Retinal Degeneration - Pipeline Insight, 2018

  • Drug Pipelines
  • 217 Pages
From
Glaucoma - Pipeline Review, H2 2018 - Product Thumbnail Image

Glaucoma - Pipeline Review, H2 2018

  • Drug Pipelines
  • 308 Pages
From
Ocular Hypertension - Pipeline Review, H2 2018 - Product Thumbnail Image

Ocular Hypertension - Pipeline Review, H2 2018

  • Drug Pipelines
  • 130 Pages
From
Wet Age-related Macular Degeneration - Pipeline Insights, 2017 - Product Thumbnail Image

Wet Age-related Macular Degeneration - Pipeline Insights, 2017

  • Drug Pipelines
  • 106 Pages
From
Loading Indicator
adroll